Stay updated on Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial
Sign up to get notified when there's something new on the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page.

Latest updates to the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page
- CheckyesterdayChange DetectedThe revision tag on the page was updated from v3.6.0 to v3.6.2, signaling a minor software version update. No study details or public content appear to be altered by this change.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedNew navigation/help sections were added, including How to Read a Study Record, Common Questions, How to Join a Study, and a standardized Intervention/Treatment label. The page now shows recruitment status as No longer looking for participants, and the revision tag was updated from v3.5.5 to v3.6.0 while the older label variant was removed.SummaryDifference0.3%

- Check22 days agoChange DetectedThe page shows an updated Revision label from v3.5.4 to v3.5.5. This is a non-content update reflecting a new release version of the page and does not alter any study details, locations, or navigation.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision: v3.5.4 is now displayed on the page, replacing the previous Revision: v3.5.3. This indicates a minor version update and does not alter the study details or content on the page.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision: v3.5.3 has been added, replacing Revision: v3.5.2. This indicates a new version of the document, usually due to minor updates or corrections.SummaryDifference0.0%

- Check72 days agoChange DetectedAdded revision: v3.5.2 and removed revision: v3.5.0. This is a minor site-version update that does not affect the study details.SummaryDifference0.0%

Stay in the know with updates to Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page.